March 1, 2025

March 2025 Provider Newsletter

Contents

AdministrativeCommercialMarch 1, 2025

New coding guidelines: include the anatomic modifier

AdministrativeCommercialMarch 1, 2025

Update: Drug claims edits to focus on FDA‑approved indications

Digital SolutionsCommercialNovember 1, 2024

Adopting digital member ID cards

Digital SolutionsCommercialMedicare AdvantageMarch 1, 2025

Reminder: provider data attestation

Digital SolutionsCommercialMedicare AdvantageMarch 1, 2025

Electronic Explanation of Payment starting in June

Digital SolutionsCommercialMedicare AdvantageMarch 1, 2025

Electronic payments starting in June 2025

Digital SolutionsCommercialFebruary 4, 2025

Expansion of Carelon Medical Benefits Management, Inc. programs

Education & TrainingCommercialMedicare AdvantageJanuary 1, 2025

Enhance billing and coding accuracy with new Payment Integrity training

Policy UpdatesMedicare AdvantageFebruary 14, 2025

Clinical Criteria updates

Medical Policy & Clinical GuidelinesCommercialFebruary 18, 2025

MCG Care Guidelines 29th edition

Medical Policy & Clinical GuidelinesMedicare AdvantageFebruary 20, 2025

MCG Care Guidelines 29th edition

Prior AuthorizationCommercialMarch 1, 2025

Precertification list change notification March 1, 2025

Federal Employee Program (FEP)CommercialMarch 1, 2025

Changes in Postal Service Health Benefits for 2025

NHBCBS-CRCM-078137-25 , CPN78072

AdministrativeCommercialMarch 1, 2025

New coding guidelines: include the anatomic modifier

For claims processed on or after April 1, 2025, our claim editing system will align with the AMA CPT® Manual and HCPCS Level II Manual correct coding guidelines for billing anatomical modifiers 50, RT, and LT.

According to the AMA CPT and HCPCS Level II manuals, the appropriate anatomical modifier must be appended to the appropriate procedure code. These modifiers designate the area or part of the body on which a service is being performed.

If you believe a claim reimbursement decision should be reviewed, please follow the claims dispute process outlined in the Provider Manual.

If you have questions about this notification, contact your network manager or provider relationship management representative.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of New Hampshire, Inc. HMO plans are administered by Anthem Health Plans of New Hampshire, Inc. and underwritten by Matthew Thornton Health Plan, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-077346-25

AdministrativeCommercialMarch 1, 2025

Update: Drug claims edits to focus on FDA‑approved indications

Beginning April 1, 2025, claims processed and submitted with pharmaceutical drug procedure codes must be supported by an approved FDA indication or an approved off‑label indication as listed in the CMS-defined list of pharmaceutical compendia. The approved off‑label usage listed in the compendia is determined using evidence‑based criteria from clinical trials and studies.

Drug procedure codes that have a prior authorization requirement or medical policy are excluded from this enhancement.

If you believe a claim reimbursement decision should be reviewed, please follow the normal claims dispute process outlined in the provider manual and include the portion of the medical record relevant to the drug provided.

If you have questions about this notification, contact your contract manager or provider relationship management representative.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of New Hampshire, Inc. HMO plans are administered by Anthem Health Plans of New Hampshire, Inc. and underwritten by Matthew Thornton Health Plan, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-075142-24

AdministrativeCommercialMarch 1, 2025

Certain modifiers for outpatient claims will receive prepayment coding review

Beginning April 1, 2025, we will update our prepayment coding validation review process for outpatient claims to include claims submitted with modifiers 24, 25, 58, 59, 78, 79, E1–E4, F1–F9, TA, LT, RT, LC, LD, RC, LM, RI, XE, XP, XS, and XU.

This updated review aligns with published reimbursement policies and National Correct Coding Initiative (NCCI) correct coding guidelines that require proper modifier usage and submission. We will evaluate the use of modifiers in conjunction with the edits they bypass (such as the NCCI). Registered nurses and coders who are clinical analysts will review claims pending validation, along with any related services, to determine whether it is appropriate for the modifier to bypass the edit.

If you believe a claim reimbursement decision should be reviewed, please follow the claims payment dispute process outlined in your provider manual, which is available in our provider manual.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of New Hampshire, Inc. HMO plans are administered by Anthem Health Plans of New Hampshire, Inc. and underwritten by Matthew Thornton Health Plan, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-076807-25

Digital SolutionsCommercialNovember 1, 2024

Adopting digital member ID cards

Anthem has a continued mission to leverage digital technology to provide enhanced services for both members and care providers. We encourage the support of care providers in accepting digital ID cards instead of a physical member ID card. As members increasingly use digital ID cards, care providers may need to implement changes in their processes to accept this format.

Due to recent enhancements, care providers can bypass the request for cards by accessing Availity.com. If a copy of a physical member identification card is needed, a member can email, fax, or access card details saved in their digital wallet. As a reminder, care providers can also access eligibility and benefit information without the health care identification (HCID). This makes both check-ins and submitting claims easier and faster.

Anthem is dedicated to providing digital solutions that transform both care provider and payer interactions. Thank you in advance for your continued partnership and support in empowering our members to use their digital ID cards. With your help, we can continually build towards a future of shared success.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of New Hampshire, Inc. HMO plans are administered by Anthem Health Plans of New Hampshire, Inc. and underwritten by Matthew Thornton Health Plan, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-069066-24, MULTI-BCBS-CM-077976-25

Digital SolutionsCommercialMedicare AdvantageMarch 1, 2025

Reminder: provider data attestation

At a glance:

  • Care providers contracted with us need to verify and update their demographic data every 90 days using the provider data management (PDM) feature in Availity Essentials.
  • Updating and attesting data are critical for maintaining accurate service directories for members and noncompliance with these requirements can result in removal from the online provider directory.
  • Availity Essentials provides digital applications that enable users to monitor submitted demographic updates in real time, review the history of previously verified data, and manage multiple updates within one spreadsheet via the Upload Roster feature.

What are the requirements for the attestation of demographic data?

We require our contracted care provider partners to attest to their demographic data every 90 days. Maintaining your provider data is critical as it results in improved connection to members seeking care, supports the accuracy of claims processing, and allows for timely reimbursement, while aligning to a bold purpose of improving the health of humanity.

How do I update and attest to my data?

We require the use of the PDM capability available on Availity Essentials to update your provider or facility data. There are two options within Availity Essentials PDM that are available at no cost to care providers:

  • Multipayer platform, which includes Directory Verification and Core PDM: allows care providers to make required updates using Directory Verification and changes using Core PDM
  • Roster upload: allows care providers to submit multiple updates within one spreadsheet via the Upload Roster feature (The Upload Roster feature is currently only available and shared with the health plan.)

Both the multipayer platform and Roster Upload feature satisfy your 90‑day attestation requirement.

To attest to your provider data:

    1. Log in to https://Availity.com.
    2. Navigate to My Providers > Provider Data Management.
    3. Select the action menu next to the business whose information you want to verify.
    4. Select Verify Directory Listing.
    5. Review each set of data for accuracy.
    6. Once complete, select Submit Verified Profile.

Organizations with no changes since their last submission may see a Quick Verify button that allows for directory verification in one click.

Individuals registered for their TIN within the Availity Manage My Organization application on Availity Essentials will receive periodic automated emails and notifications in the Notification Center on Availity Essentials reminding them when their attestation is due or overdue.

How do I access Availity Essentials and the PDM application?

To access the PDM application, log on to https://Availity.com and select My Providers > Provider Data Management to begin using PDM. Administrators will automatically be granted access to PDM. Additional staff may be given access to PDM by an administrator. To find your administrator, go to My Account Dashboard > My Account > Organization(s) > Administrator Information.

Within PDM you also have the ability to:

  • Monitor submitted demographic updates in real time with a digital dashboard.
  • Review the history of previously verified data.

Why is updating and attesting to my data important?

Our members use Find Care to make informed decisions about their healthcare and find quality doctors and hospitals. Keeping your data up to date ensures members have access to you when they need it the most.

Failure to complete the 90‑day attestation requirement puts your organization at risk of being classified as non‑compliant with the health plan’s policies and procedures and may result in removal from the online provider directory.

What if I’m not registered for Availity Essentials yet?

If you aren’t registered to use Availity Essentials, signing up is easy and secure. There is no cost to register or to use any of the digital applications. Start by going to https://Availity.com and selecting New to Availity? Get Started at the top of the home screen to access the registration page. If you have more than one TIN, ensure you have registered all TINs associated with your account.

If you have questions regarding registration, reach out to Availity Client Services at 800‑AVAILITY (282‑4548).

How do I get training on the Availity Essentials PDM tool?

You can learn about and attend one of our training opportunities by visiting here (apps.availity.com):

  • For more information on PDM, check out the Quick Start Guide here (apps.availity.com) using your Availity Essentials user ID and password.
  • For more information about the Roster Upload process:
    • See the Roster Submission Guide on https://Availity.com > Payer Spaces > Select Payer Tile > Resources > Roster Submission Guide using PDM.
    • Find training specifically for the Standard Template and Rules of Engagement by listening to our recorded webinar on our provider Learning Hub.
    • Take an on‑demand class hosted by Availity Essentials on the Learning Hub to learn about PDM.

What if I’m a behavioral health care provider?

If you are a behavioral health care provider and assigned to Carelon Behavioral Health, Inc., follow the Carelon Behavioral Health process for attestation. Council for Affordable Quality Healthcare (CAQH) care providers should attest, confirm, or update their data through the CAQH website. Non‑CAQH care providers and facilities should attest, confirm, or update their data directly with Carelon Behavioral Health.

Contact us

Availity Chat with Payer is available during normal business hours. Get answers to your questions about eligibility, benefits, authorizations, claims status, and more. To access Availity Essentials, go to https://Availity.com and select the appropriate payer space tile from the drop‑down. Then, select Chat with Payer and complete the pre‑chat form to start your chat.

For additional support, visit the Contact Us section of our provider website for the appropriate contact.

Carelon Behavioral Health is an independent company providing utilization management services on behalf of the health plan.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of New Hampshire, Inc. HMO plans are administered by Anthem Health Plans of New Hampshire, Inc. and underwritten by Matthew Thornton Health Plan, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CRCM-078363-25-CPN78193

Digital SolutionsCommercialMedicare AdvantageMarch 1, 2025

Electronic Explanation of Payment starting in June

Electronic access to your Explanation of Payment, through 835 electronic remittance advice (ERA), or Remittance on Availity (which may include Virtual Credit Cards) is secure and fast. To enroll in or disenroll from ERA, visit https://Availity.com. For Availity support, call Availity Client Services at 800-282-4548.

For secure and fast transmission of the virtual credit card (VCC), payment remittance, or Explanation of Payment (EOP), we will no longer send paper EOPs and VCCs. Using the Availity Remit Viewer application, you can view or download digital copies of 835 ERAs and EOPs. You can also view the VCC to accelerate your reimbursement.

Take advantage of the secure and streamlined experience to access the information you need anytime on the Availity Essentials platform. Over time, you’ll receive fewer letters and faxes from us. If you have registration questions or need Availity Essentials help, call Availity Client Services at 800-282-4548. If you still need a paper copy of the EOP, call Provider Services.

For care providers who do not access Availity Essentials, you will receive virtual credit cards in paper form and paper EOPs. If you still need a paper check payment, call 800-833-7130 and provide them with the TINs of your organization that you wish not to receive VCCs.

Thank you for your support as we transition to more electronic payment options. Through our efforts, we are committed to reducing administrative burden and ensuring active involvement with you, our care provider partners.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of New Hampshire, Inc. HMO plans are administered by Anthem Health Plans of New Hampshire, Inc. and underwritten by Matthew Thornton Health Plan, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NHBCBS-CRCM-077218-24-CPN67758

Digital SolutionsCommercialMedicare AdvantageMarch 1, 2025

Electronic payments starting in June 2025

Electronic claims payment through electronic funds transfer (EFT) is the fastest and most secure way to receive payment. The EFT deposit is assigned a trace number matched to the 835 electronic remittance advice (ERA) for simple payment reconciliation. Visit EnrollSafe at https://enrollsafe.payeehub.org to enroll in or disenroll from EFT. If you need EFT help, email Support@payeehub.org.

Care providers not enrolled in EFT may receive payments via a virtual credit card (VCC) in lieu of paper checks. VCCs allow care providers to process payments as credit card transactions. Credit card processing fees may apply. Contact your merchant processor or financial institution for specific costs.

Depending on the electronic payment method, Anthem or affiliated companies may receive some form of compensation. Signing up for EFT automatically opts care providers out of VCCs.

If you still need a check payment, call 800‑833-7130 and provide them with the TINs of your organization that you do not want to receive VCCs.

Thank you for your support as we transition to more electronic payment options. Through our efforts, we are committed to reducing administrative burden and ensuring active involvement with you — our care provider partners.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of New Hampshire, Inc. HMO plans are administered by Anthem Health Plans of New Hampshire, Inc. and underwritten by Matthew Thornton Health Plan, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NHBCBS-CRCM-077220-24-CPN74571

Digital SolutionsCommercialFebruary 4, 2025

Expansion of Carelon Medical Benefits Management, Inc. programs

  • Effective March 1, 2025, Carelon Medical Benefits Management will begin conducting clinical appropriateness reviews of cardiovascular, musculoskeletal, and surgical procedures.
  • New outpatient utilization management also includes fertility procedures and other medical services for select insurance plans.
  • Anthem will continue to perform reviews of transportation services.
  • Providers are encouraged to use an online portal for service preauthorization, with resources and training available for guidance.


Carelon Medical Benefits Management will begin accepting prior authorization requests on February 24, 2025, for dates of service on or after March 1, 2025.

Members included in the new program

Updates to Carelon Medical Benefits Management programs apply to select local fully insured members and members covered under self‑insured (ASO) benefit plans with services medically managed by Carelon Medical Benefits Management. This notice does not apply to certain HMO, BlueCard®, Medicare Advantage, Medicaid, Medicare supplemental, or Federal Employee Program® (FEP®) plans. For more information, please call the phone number on the back of the member ID card.

Pre‑service review requirements

For procedures scheduled to begin on or after March 1, 2025, all care providers need to contact Carelon Medical Benefits Management to obtain a pre‑service review for the services, including, but not limited to, the following non‑emergency modalities. Please refer to the Clinical Guidelines at Anthem.com > Providers > Provider Resources > Policies, Guidelines & Manuals for complete code lists.

Note: All codes will be reviewed for medical necessity for the requested service and not for site of care.

The tables below list our Clinical UM Guidelines and Medical Policies for medical necessity review.

Program — Additional outpatient UM

Services

Medical Policies or Clinical Guidelines

Fertility

CG-MED-68

Therapeutic Apharesis

MED.00101

Hyperbaric Oxygen Therapy

CG-MED-89

Physiologic Record of Tremor

CG-MED-73

Parenteral Nutrition

DME.00011

Imaging Eval. of Skin Lesions

DME.00048

Virtual Reality-Assisted Therapy Systems

MED.00011

Quantitative Sensory Test

MED.00082

Automated Nerve Conduction

MED.00092

Bioimpedance Spectroscopy

MED.00103

Autonomic Test

MED.00105

Monitor Intraocular Pressure

MED.00112

Seizure Monitoring

MED.00118

Home Visual Field Monitor

MED.00130

Eye Movement Analysis for Dx of Concussion

MED.00131

Colonic Irrigation

MED.00137

Electrical Stim. Tx. for Pain & Other Conditions

MED.00141

Sensory Stim. for Brain Injury

MED.00002

Automated Evacuation of Meibomian Gland

MED.00004

Selected Sleep Testing

CG-MED-66

CG-MED-88

CG-SURG-35

LAB.00045

Program — Cardiovascular

Services

Medical Policies or Clinical Guidelines

Carotid Sinus Baroreceptor Stim. Devices

CG-SURG-106

Venous angioplasty w/wo stent placement

CG-SURG-119

Vein embolization tx for pelvic congestion syndrome and varicocele

CG-SURG-28

Tx of varicose veins

CG-SURG-76

Artery stent placement w/wo angioplasty

CG-SURG-83

Embolization proc.

Dialysis circuit proc.

CG-SURG-93

RAD.00059

SURG.00062

SURG.00124

Program — Musculoskeletal

Services

Medical Policies or Clinical Guidelines

Peripheral Nerve Blocks for Tx of Neuropathic Pain Implant of Nerve Stim. Devices

SURG.00140

SURG.00158

SURG.00112

Program — Surgical

Services

Medical Policies or Clinical Guidelines

Anesthesia for Dental Svcs.

SURG.00045

Skin Related Cosmetic & Reconstructive Services

SURG.00112

Balloon Dilation of Eustachian Tubes

SURG.00144

Functional Endoscopic Sinus Surgery

SURG.00129

Bronchial Thermoplasty

ANC.00007

Balloon Sinus Ostial Dilation

CG-MED-41

Cochlear & Auditory Brainstem Implants

CG-MED-79

Implantable Hearing Aids

CG-MED-81

Surg. Tx for OSA & Snoring

CG-SURG-03

Drug-Eluting Devices to Maintain Sinus Ostial Patency

CG-SURG-08

Minimally Invasive Tx of Posterior Nasal Nerve for Rhinitis

CG-SURG-09

Temporomandibular Disorders

CG-SURG-105

Septoplasty

CG-SURG-117

Nasal Valve Repair

CG-SURG-118

Bariatric Surgery

CG-SURG-12

MRI Guided US Ablation for Non-Oncologic Indications

CG-SURG-120

Uterine Fibroid Ablation

CG-SURG-18

Sacral Nerve Stim. Tx of Neurogenic Bladder secondary to Spinal Cord Injury

CG-SURG-24

Vagus Nerve Stim.

CG-SURG-61

Ablation for Solid Tumors Outside the Liver

CG-SURG-71

Irreversible Electroporation

CG-SURG-73

Corneal Collagen Cross Linking

CG-SURG-79

Intraocular Telescope

CG-SURG-81

Automated Evacuation of Meibomian Gland

CG-SURG-82

Correct Intraocular Lenses

CG-SURG-83

Viscocanalostomy & Canaloplasty

CG-SURG-84

Intraocular Anterior Segment Aqueous Drainage Devices

CG-SURG-88

Extracorporeal Shock Wave Therapy

CG-SURG-95

Implant of Nerve Stim. Devices

CG-SURG-96

Implanted Artificial Iris Devices

CG-SURG-99MCG: ISC: S-660/660-RRG: Hysterectomy, Vaginal

Implanted Port Delivery Systems for Ocular Disease

MCG: ISC: S-450/450-RRG/5450: Laparotomy for Gynecologic Surgery, Including Myomectomy, Oophorectomy, and Salpingectomy

Implantable Infusion Pumps

MCG: ISC: S-660/660-RRG: Hysterectomy, Vaginal

Tx for Urinary & Fecal Incontinence

MCG: ISC: S-665/665-RRG: Hysterectomy, Laparoscopic

Reduction Mammaplasty

MCG: ISC: S-775/775-RRG: Laparoscopic Gynecologic Surgery, Including Myomectomy, Oophorectomy, and Salpingectomy

Mastectomy for Gynecomastia

MED.00057

Panniculectomy & Abdominoplasty

MED.00103

Regenerative Cell Therapy & Soft Tissue Augmentation

MED.00132

Products for Wound Healing & Soft Tissue Grafting

SURG.00010

Surg. & Ablative Tx for Chronic Headaches

SURG.00011

Intraoperative Assess. of Surgical Margins During Breast-Conserving Surg.

SURG.00061

Mandibular/Maxillary Surg.

SURG.00077

Blepharoplasty, Repair & Brow Lift

SURG.00079

Internal Rib Fixation Systems

SURG.00084

Prostate Saturation Biopsy

SURG.00095

Focal Laser Ablation for Tx of Prostate Cancer

SURG.00096

Penile Prosthesis Implantation

SURG.00107

Diaphragmatic/Phrenic Nerve Stim. & Pacing Systems

SURG.00118

US Ablation for Oncologic Indications

SURG.00120

Radiofrequency Ablation of Renal Sympathetic Nerves

SURG.00126

Hysterectomy

SURG.00132

Laparoscopic Gynecologic Surgery

SURG.00135

Myomectomy

SURG.00139

Transurethral Destruction, Prostate Tissue

SURG.00156

Nerve Block Therapy for Tx of Headache & Neuralgia

SURG.00157

SURG.00159

SURG.00160

To determine if prior authorization is needed for a member on or after March 1, 2025, contact the Provider Services phone number on the back of the member’s ID card for benefit information. Care providers using the Interactive Care Reviewer (ICR) tool on http://Availity.com to pre‑certify an outpatient procedure will receive a message referring the provider to Carelon Medical Benefits Management. (Note: ICR cannot accept prior authorization requests for services administered by Carelon Medical Benefits Management.)

Care providers should continue to submit pre‑service review requests to Carelon Medical Benefits Management using the convenient online service provided on the Carelon Medical Benefits Management provider website. The website is available 24 hours a day, seven days a week, and processes requests in real time using Clinical Criteria. To register, go to https://providerportal.com.

For more information

For resources to help your practice get started with the cardiology, musculoskeletal, radiology, sleep, surgical procedures, and radiation oncology programs, visit:

Cardiovascular Solution | Carelon Insights

Radiology Solution | Carelon Insights

Sleep Solution | Sleep Healthcare | Carelon Insights

Surgical Procedures Solution | Carelon Insights

Radiation Oncology Solution | Carelon Insights

Additional Outpatient Utilization Management

Sign up at provider training for provider training for the additional outpatient UM:

  • Wednesday, February 5, 2025, at 12 p.m. ET/11 a.m. CT
  • Wednesday, February 12, 2025, at 12 p.m. ET/11 a.m. CT
  • Friday, February 21, 2025, at 11 a.m. ET/10 a.m. CT
  • Wednesday, February 26, 2025, at 12 p.m. ET/11 a.m. CT
  • Wednesday, March 5, 2025, at 12 p.m. ET/11 a.m. CT

Our website, Anthem.com, provides information and tools such as order entry checklists, Clinical Guidelines, and FAQ. You can also contact your provider relationship management representative with any questions.

Through genuine collaboration, we can simplify access to care and help you deliver high‑quality, equitable healthcare.

Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of New Hampshire, Inc. HMO plans are administered by Anthem Health Plans of New Hampshire, Inc. and underwritten by Matthew Thornton Health Plan, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-076017-24

Education & TrainingCommercialMedicare AdvantageJanuary 1, 2025

Enhance billing and coding accuracy with new Payment Integrity training

We’re excited to introduce two new Payment Integrity trainings available on our Digital Solutions Learning Hub:

  • Payment Integrity: Emergency Dept Evaluation and Management Services
  • Payment Integrity: Outpatient Evaluation and Management Services

With an initial focus on these two key educational initiatives, our purpose is to amplify your billing and coding accuracy.

More trainings will be announced throughout the year.

Discover what our Digital Solutions Learning Hub has to offer.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of New Hampshire, Inc. HMO plans are administered by Anthem Health Plans of New Hampshire, Inc. and underwritten by Matthew Thornton Health Plan, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

KYBCBS-CRCM-072244-24-CPN72085, MULTI-BCBS-CRCM-072264-24-CPN72085, MULTI-BCBS-CRCM-075953-24-CPN75258, MULTI-BCBS-CRCM-077839-25-CPN77515, MULTI-BCBS-CRCM-080188-25-CPN79720

WebinarsCommercialFebruary 21, 2025

Start 2025 with an easy way to earn continuing education credits

Join our on‑demand webinar on improving antibiotic use in the outpatient setting, led by Dr. Emily McDonald, MD, MPH, and Guillermo Sanchez, PA‑C, MPH, MSHS, from the CDC’s Office of Antibiotic Stewardship.

The webinar highlights key strategies such as proper diagnosis, adherence to clinical guidelines, and educational interventions. It will also address common misconceptions regarding patient satisfaction and prescribing practices. Additionally, the session will discuss tools and resources, such as HEDIS® quality measures and communication training, available to help clinicians improve their antibiotic stewardship practices.

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

Program objectives:

  • Review the epidemiology of outpatient antibiotic use in the U.S.
  • Identify high‑priority conditions where antibiotic prescribing can be improved.
  • Describe evidence‑based interventions that can improve antibiotic use.
  • Address common myths related to antibiotic use.

Visit: Improving Antibiotic Use for Acute Respiratory Infections (This link works best with the Chrome browser.)

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of New Hampshire, Inc. HMO plans are administered by Anthem Health Plans of New Hampshire, Inc. and underwritten by Matthew Thornton Health Plan, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-077493-25-CPN77017

Policy UpdatesMedicare AdvantageFebruary 14, 2025

Clinical Criteria updates

Effective March 24, 2025

Summary

The Pharmacy and Therapeutic (P&T) Committee approved the following Clinical Criteria applicable to the medical drug benefit for Anthem. These policies were developed, revised, or reviewed to support clinical coding edits.

Visit Clinical Criteria to search for specific policies. For questions or additional information, use this email.

Please see the explanation/definition for each category of Clinical Criteria below:

  • New: newly published criteria
  • Revised: addition or removal of medical necessity requirements, new document number

Please share this notice with other members of your practice and office staff.

Please note:

  • The Clinical Criteria listed below applies only to the medical drug benefits contained within the member’s medical plan. This does not apply to pharmacy services.
  • This notice is meant to inform the provider of new or revised criteria that has been adopted by Anthem only. It does not include details regarding any authorization requirements. Authorization rules are communicated via a separate notice.

Effective Date

Clinical Criteria Number

Clinical Criteria Title

New or Revised

March 24, 2025

CC-0272

Aucatzyl (obecabtagene autoleucel)

New

March 24, 2025

CC-0273

Vyloy (zolbetuximab-clzb)

New

March 24, 2025

CC-0223

Imjudo (tremelimumab-actl)

Revised

March 24, 2025

CC-0056

Selected Injectable 5HT3 Antiemetic Agents

Revised

March 24, 2025

CC-0148

Agents for Hemophilia B

Revised

March 24, 2025

CC-0149

Select Clotting Agents for Bleeding Disorders

Revised

March 24, 2025

CC-0065

Agents for Hemophilia A and von Willebrand Disease

Revised

March 24, 2025

CC-0124

Keytruda (pembrolizumab)

Revised

March 24, 2025

CC-0151

Yescarta (axicabtagene ciloleucel)

Revised

March 24, 2025

CC-0187

Breyanzi (lisocabtagene maraleucel)

Revised

March 24, 2025

CC-0204

Tivdak (tisotumab vedotin-tftv)

Revised

March 24, 2025

CC-0226

Elahere (mirvetuximab)

Revised

March 24, 2025

CC-0125

Opdivo (nivolumab)

Revised

March 24, 2025

CC-0128

Tecentriq (atezolizumab)

Revised

March 24, 2025

CC-0011

Ocrevus (ocrelizumab)/Ocrevus Zunovo (ocrelizumab/hyaluronidase-ocsq)

Revised

March 24, 2025

CC-0173

Enspryng (satralizumab-mwge)

Revised

March 24, 2025

CC-0170

Uplizna (inebilizumab-cdon)

Revised

March 24, 2025

CC-0199

Empaveli (pegcetacoplan)

Revised

March 24, 2025

CC-0041

Complement Inhibitors

Revised

March 24, 2025

CC-0071

Entyvio (vedolizumab)

Revised

March 24, 2025

CC-0064

Interleukin-1 Inhibitors

Revised

March 24, 2025

CC-0042

Monoclonal Antibodies to Interleukin-17

Revised

March 24, 2025

CC-0066

Monoclonal Antibodies to Interleukin-6

Revised

March 24, 2025

CC-0050

Monoclonal Antibodies to Interleukin-23

Revised

March 24, 2025

CC-0078

Orencia (abatacept)

Revised

March 24, 2025

CC-0063

Ustekinumab Agents

Revised

March 24, 2025

CC-0062

Tumor Necrosis Factor Antagonists

Revised

March 24, 2025

CC-0003

Immunoglobulins

Revised

March 24, 2025

CC-0073

Alpha-1 Proteinase Inhibitor Therapy

Revised

March 24, 2025

CC-0043

Monoclonal Antibodies to Interleukin-5

Revised

March 24, 2025

CC-0029

Dupixent (dupilumab)

Revised

March 24, 2025

CC-0105

Vectibix (panitumumab)

Revised

March 24, 2025

CC-0095

Bortezomib (Boruzu, Velcade)

Revised

March 24, 2025

CC-0161

Sarclisa (isatuximab-irfc)

Revised

March 24, 2025

CC-0201

Rybrevant (amivantamab-vmjw)

Revised

March 24, 2025

CC-0120

Kyprolis (carfilzomib)

Revised

March 24, 2025

CC-0197

Jemperli (dostarlimab-gxly)

Revised

March 24, 2025

CC-0255

Loqtorzi (toripalimab-tpzi)

Revised

March 24, 2025

CC-0002

Colony Stimulating Factor Agents

Revised

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of New Hampshire, Inc. HMO plans are administered by Anthem Health Plans of New Hampshire, Inc. and underwritten by Matthew Thornton Health Plan, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-075809-24-CPN74713

Medical Policy & Clinical GuidelinesCommercialFebruary 18, 2025

MCG Care Guidelines 29th edition

Effective June 1, 2025, Anthem will upgrade to the 29th edition of MCG Care Guidelines for the following modules. Below is high level summary of the updates and is not intended to be all inclusive:

  • Behavioral Health Care (BHG):
    • The guidelines for substance‑related disorders have been updated to allow users to identify ASAM citations more easily within MCG content. Benchmarks have been added to the guidelines for Applied Behavioral Analysis, Neuropsychological Testing, Psychological Testing, and Urine Toxicology Testing.
  • Inpatient & Surgical Care (ISC):
    • Five new observation care guidelines have been added. Also, a new mean arterial pressure (MAP) calculator has been added.
  • General Recovery Care (GRG):
    • A new Hospital‑at-Home General Recovery Guideline has been added.
  • Recovery Facility Care (RFC):
    • The discharge planning section for Inpatient Rehabilitation Facility guidelines was expanded.

If you have questions, please contact Provider Services via the number on the back of our member ID card.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of New Hampshire, Inc. HMO plans are administered by Anthem Health Plans of New Hampshire, Inc. and underwritten by Matthew Thornton Health Plan, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NHBCBS-CM-074755-24-CPN74544

Medical Policy & Clinical GuidelinesMedicare AdvantageFebruary 20, 2025

MCG Care Guidelines 29th edition

Effective June 1, 2025, Anthem will upgrade to the 29th edition of MCG Care Guidelines for the following modules. Below is high level summary of the updates and is not intended to be all inclusive:

  • Behavioral Health Care (BHG):
    • The guidelines for substance‑related disorders have been updated to allow users to identify ASAM citations more easily within MCG content. Benchmarks have been added to the guidelines for Applied Behavioral Analysis, Neuropsychological Testing, Psychological Testing, and Urine Toxicology Testing.
  • Inpatient & Surgical Care (ISC):
    • Five new observation care guidelines have been added. Also, a new mean arterial pressure (MAP) calculator has been added.
  • General Recovery Care (GRG):
    • A new Hospital‑at-Home General Recovery Guideline has been added.
  • Chronic Care (CCG):
    • New guidelines have been added to self‑management and low‑intensity disease management pediatric guidelines.

If you have questions, please contact Provider Services via the number on the back of our member ID card.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of New Hampshire, Inc. HMO plans are administered by Anthem Health Plans of New Hampshire, Inc. and underwritten by Matthew Thornton Health Plan, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-074776-24-CPN74543

Prior AuthorizationCommercialMarch 1, 2025

Precertification list change notification March 1, 2025

The following services will be added to precertification for the effective dates listed below.

To obtain precertification, providers can access Availity Essentials at https://Availity.com or call Anthem’s Utilization Management department using the number on the back of the member’s identification card. Service preapproval is based on member’s benefit plan/eligibility at the time the service is reviewed/approved.

If the requirements are not met, those services may be deemed ineligible for payment. Providers may appeal online through Availity Essentials or phone Anthem Provider Services with additional information which may include medical records

Precertification can help avoid unnecessary charges or penalties by helping to ensure that the member's care is medically necessary and administered at an appropriate network facility and by a network provider.
Add To Precertification
Criteria

Criteria Description

Code

Effective Date

DME.00011

Electrical Stimulation as a Treatment for Pain and Other Conditions: Surface and Percutaneous Devices

A4543

6/1/2025

DME.00011

Electrical Stimulation as a Treatment for Pain and Other Conditions: Surface and Percutaneous Devices

A4544

6/1/2025

DME.00011

Electrical Stimulation as a Treatment for Pain and Other Conditions: Surface and Percutaneous Devices

E0721

6/1/2025

DME.00011

Electrical Stimulation as a Treatment for Pain and Other Conditions: Surface and Percutaneous Devices

E0743

6/1/2025

DME.00012

Intrapulmonary Percussive Ventilation Devices

A7021

6/1/2025

DME.00012

Intrapulmonary Percussive Ventilation Devices

E0469

6/1/2025

DME.00052

Brain Computer Interface Rehabilitation Devices

E0738

6/1/2025

LAB.00003

In Vitro Chemosensitivity Assays and In Vitro Chemoresistance Assays

0511U

6/1/2025

LAB.00015

Detection of Circulating Tumor Cells

0490U

6/1/2025

LAB.00015

Detection of Circulating Tumor Cells

0491U

6/1/2025

LAB.00015

Detection of Circulating Tumor Cells

0492U

6/1/2025

LAB.00026

Systems Pathology and Multimodal Artificial Intelligence Testing for Cancerous and Precancerous Conditions

Previously titled: Systems Pathology and Multimodal Artificial Intelligence Testing for Prostate Cancer

0108U

6/1/2025

LAB.00033

Protein Biomarkers for the Screening, Detection and Management of Prostate Cancer

0495U

6/1/2025

LAB.00040

Serum Biomarker Tests for Risk of Preeclampsia

0482U

6/1/2025

LAB.00046

Testing for Biochemical Markers for Alzheimer's Disease

0479U

6/1/2025

LAB.00046

Testing for Biochemical Markers for Alzheimer's Disease

0503U

6/1/2025

LAB.00050

Metagenomic Sequencing for Infectious Diseases in the Outpatient Setting

0480U

6/1/2025

LAB.00051

Per‑ and Polyfluoroalkyl Substances PFAS Testing

0394U

6/1/2025

LAB.00051

Per‑ and Polyfluoroalkyl Substances PFAS Testing

0457U

6/1/2025

LAB.00051

Per‑ and Polyfluoroalkyl Substances PFAS Testing

82542

6/1/2025

LAB.00051

Per‑ and Polyfluoroalkyl Substances PFAS Testing

83921

6/1/2025

MED.00134

Non‑invasive Heart Failure and Arrhythmia Management and Monitoring Systems

Previously titled: Non‑invasive Heart Failure and Arrhythmia Management and Monitoring System

93701

6/1/2025

MED.00135

Gene Therapy for Hemophilia

C9172

6/1/2025

MED.00150

Hepzato Kit™ (melphalan hepatic delivery system)

J9248

6/1/2025

SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

A2027

6/1/2025

SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

A2028

6/1/2025

SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

A2029

6/1/2025

SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

Q4334

6/1/2025

SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

Q4335

6/1/2025

SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

Q4336

6/1/2025

SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

Q4337

6/1/2025

SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

Q4338

6/1/2025

SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

Q4339

6/1/2025

SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

Q4340

6/1/2025

SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

Q4341

6/1/2025

SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

Q4342

6/1/2025

SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

Q4343

6/1/2025

SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

Q4344

6/1/2025

SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

Q4345

6/1/2025

SURG.00128

Implantable Left Atrial Hemodynamic Monitor

0933T

6/1/2025

SURG.00128

Implantable Left Atrial Hemodynamic Monitor

0934T

6/1/2025

SURG.00135

Renal Sympathetic Nerve Ablation

0935T

6/1/2025

SURG.00153

Cardiac Contractility Modulation Therapy

0915T

6/1/2025

SURG.00153

Cardiac Contractility Modulation Therapy

0916T

6/1/2025

SURG.00153

Cardiac Contractility Modulation Therapy

0917T

6/1/2025

SURG.00153

Cardiac Contractility Modulation Therapy

0918T

6/1/2025

SURG.00153

Cardiac Contractility Modulation Therapy

0919T

6/1/2025

SURG.00153

Cardiac Contractility Modulation Therapy

0920T

6/1/2025

SURG.00153

Cardiac Contractility Modulation Therapy

0921T

6/1/2025

SURG.00153

Cardiac Contractility Modulation Therapy

0922T

6/1/2025

SURG.00153

Cardiac Contractility Modulation Therapy

0923T

6/1/2025

SURG.00153

Cardiac Contractility Modulation Therapy

0924T

6/1/2025

SURG.00153

Cardiac Contractility Modulation Therapy

0925T

6/1/2025

SURG.00153

Cardiac Contractility Modulation Therapy

0926T

6/1/2025

SURG.00153

Cardiac Contractility Modulation Therapy

0927T

6/1/2025

SURG.00153

Cardiac Contractility Modulation Therapy

0928T

6/1/2025

SURG.00153

Cardiac Contractility Modulation Therapy

0929T

6/1/2025

SURG.00153

Cardiac Contractility Modulation Therapy

0930T

6/1/2025

SURG.00153

Cardiac Contractility Modulation Therapy

0931T

6/1/2025

Add To Precertification

Criteria

Criteria Description

Code

Effective Date

RAD.00069

Absolute Quantitation of Myocardial Blood Flow Measurement

0742T

6/1/2025

RAD.00069

Absolute Quantitation of Myocardial Blood Flow Measurement

0899T

6/1/2025

RAD.00069

Absolute Quantitation of Myocardial Blood Flow Measurement

0900T

6/1/2025

RAD.00069

Absolute Quantitation of Myocardial Blood Flow Measurement

78434

6/1/2025

UM AROW #: A2024M2813
UM AROW #: A2024M2777

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of New Hampshire, Inc. HMO plans are administered by Anthem Health Plans of New Hampshire, Inc. and underwritten by Matthew Thornton Health Plan, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

NHBCBS-CM-076043-24-CPN75838, NHBCBS-CM-076037-24-CPN75769

Federal Employee Program (FEP)CommercialMarch 1, 2025

Changes in Postal Service Health Benefits for 2025

What’s changing:

Effective January 1, 2025, postal employees began to participate in the Postal Service Health Benefits Program (PSHB), a health benefits program for those under the Federal Employee Program® (FEP).

What this means for you as the provider:

Postal employees in the PSHB program have a new ID card reflecting new enrollment codes. To ensure correct claim processing, the federal employee ID cards should be validated to confirm the provider has the correct enrollment information.

In 2025, federal and USPS employees in the FEP, along with their families, will have the same coverage and benefits as before. The plan options will remain Blue Standard, Blue Basic, and Blue Focus. Only the PSHB ID card and PSHB customer service number (on the back of the card) will be new.

Below is an example of the front of the new PSHB card. A stamp symbol in the upper right corner will identify the PSHB enrollment:

Once the PSHB member is enrolled, they will have a new ID card. The back of the ID card will reflect the toll-free Customer Service and prior authorization numbers for assistance.

Additional information for all federal employees can be found on the federal employee website at https://fepblue.org.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of New Hampshire, Inc. HMO plans are administered by Anthem Health Plans of New Hampshire, Inc. and underwritten by Matthew Thornton Health Plan, Inc. Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-075976-24-CPN75169